BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6831459)

  • 1. Evaluation of the immunological and toxicological properties of MVE-2 in phase I trials.
    Rinehart JJ; Young DC; Neidhart JA
    Cancer Res; 1983 May; 43(5):2358-62. PubMed ID: 6831459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation and antitumor effects of MVE-2 in mice.
    Talmadge JE; Maluish AE; Collins M; Schneider M; Herberman RB; Oldham RK; Wiltrout RH
    J Biol Response Mod; 1984 Dec; 3(6):634-52. PubMed ID: 6334720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyran (MVE-5) reverses the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.
    Rao VS; Mitchell MS
    J Biol Response Mod; 1983; 2(1):67-80. PubMed ID: 6606020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent dose-related effects of gamma-interferon therapy on in vitro antibody-dependent cellular and nonspecific cytotoxicity by human peripheral blood monocytes.
    Weiner LM; Steplewski Z; Koprowski H; Litwin S; Comis RL
    Cancer Res; 1988 Feb; 48(4):1042-6. PubMed ID: 3123051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of MVE-2 evaluating toxicity and biologic response modification capability.
    Hainsworth JD; Forbes JT; Grosh WW; Greco FA
    Cancer Immunol Immunother; 1986; 22(1):68-71. PubMed ID: 2423241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of MVE-2 therapy in human cancer.
    Rios A; Rosenblum M; Powell M; Hersh E
    Cancer Treat Rep; 1983 Mar; 67(3):239-43. PubMed ID: 6831471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of molecular weight to antiviral and antitumor activities and toxic effects of maleic anhydride-divinyl ether (MVE) polyanions.
    Morahan PS; Barnes DW; Munson AE
    Cancer Treat Rep; 1978 Nov; 62(11):1797-803. PubMed ID: 103618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of MVE-II in metastatic malignant melanoma.
    Rinehart J; LaForge J; Gochnour D; Neidhart J
    Cancer Immunol Immunother; 1987; 24(3):244-6. PubMed ID: 3496153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemoimmunotherapy of cancer: influence of tumor burden and role of functional immune effector cells in mice.
    Schlick E; Hewetson P; Ruffmann R
    Cancer Res; 1986 Jul; 46(7):3378-83. PubMed ID: 3708572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between soluble IgG, complement and cells in lymphocyte and monocyte ADCC.
    Poston RN; Morgan RS
    Immunology; 1983 Nov; 50(3):461-9. PubMed ID: 6629417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.
    de Gast GC; Klümpen HJ; Vyth-Dreese FA; Kersten MJ; Verra NC; Sein J; Batchelor D; Nooijen WJ; Schornagel JH
    Clin Cancer Res; 2000 Apr; 6(4):1267-72. PubMed ID: 10778950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
    Milas L; Hersh EM; Hunter N
    Cancer Res; 1981 Jun; 41(6):2378-85. PubMed ID: 7237436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyran copolymer: effect of molecular weight on stem cell mobilization in mice.
    Zander AR; Spitzer G; Verma DS; Ginzbarg S; Dicke KA
    Biomedicine; 1980 May; 33(3):69-72. PubMed ID: 7448325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maleic vinyl ether activation of murine macrophages against lung-metastasizing tumors.
    Loveless SE; Munson AE
    Cancer Res; 1981 Oct; 41(10):3901-6. PubMed ID: 7285000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
    Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity.
    Nishiya K; Horwitz DA
    J Immunol; 1982 Dec; 129(6):2519-23. PubMed ID: 7142699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study of effective administration of recombinant interferon-gamma in renal cell carcinoma regarding immunological influence on peripheral blood lymphocytes].
    Kawata N; Ono M; Kodama M; Yamanaka Y; Hirakata H; Hirano D; Fuse T; Takimoto Y
    Hinyokika Kiyo; 1995 Jan; 41(1):21-6. PubMed ID: 7900565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maleic vinyl ether anhydride nephropathy: altered glomerular permeability due to an immunomodulating agent.
    Bertolatus JA
    Clin Immunol Immunopathol; 1988 Oct; 49(1):6-18. PubMed ID: 2842098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon.
    Munn DH; Armstrong E
    Cancer Res; 1993 Jun; 53(11):2603-13. PubMed ID: 8495423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.